OrganiGram Holdings Inc. (OGI.TO)
CAD 1.47
(1.38%)
CAD 1.47
(1.38%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -33.7 Million CAD | 55.27% |
| 2022 | -65.15 Million CAD | -29.27% |
| 2021 | -50.4 Million CAD | -163.75% |
| 2020 | 79.07 Million CAD | 3812.47% |
| 2019 | 2.02 Million CAD | -95.42% |
| 2018 | 44.1 Million CAD | 2725.23% |
| 2017 | 1.56 Million CAD | 165.97% |
| 2016 | -2.36 Million CAD | -169.9% |
| 2015 | 3.38 Million CAD | 2570.98% |
| 2014 | -136.99 Thousand CAD | 13.17% |
| 2013 | -157.78 Thousand CAD | 50.79% |
| 2012 | -320.59 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -79.15 Million CAD | -10.42% |
| 2024 Q1 | -41.67 Million CAD | -43.01% |
| 2024 Q2 | -71.68 Million CAD | -72.0% |
| 2023 Q4 | -29.14 Million CAD | 44.52% |
| 2023 Q1 | -69.85 Million CAD | -7.21% |
| 2023 Q2 | -61.63 Million CAD | 11.77% |
| 2023 Q3 | -52.53 Million CAD | 14.76% |
| 2023 FY | -29.14 Million CAD | 55.27% |
| 2022 Q2 | -74.44 Million CAD | 22.9% |
| 2022 Q4 | -65.15 Million CAD | 45.59% |
| 2022 FY | -65.15 Million CAD | -29.27% |
| 2022 Q1 | -96.55 Million CAD | -91.56% |
| 2022 Q3 | -119.75 Million CAD | -60.86% |
| 2021 Q2 | 7.03 Million CAD | -53.57% |
| 2021 Q3 | -53.16 Million CAD | -856.03% |
| 2021 FY | -50.4 Million CAD | -163.75% |
| 2021 Q4 | -50.4 Million CAD | 5.19% |
| 2021 Q1 | 15.14 Million CAD | -80.85% |
| 2020 FY | 79.07 Million CAD | 3812.47% |
| 2020 Q3 | 43.55 Million CAD | -5.1% |
| 2020 Q2 | 45.89 Million CAD | -12.42% |
| 2020 Q1 | 52.4 Million CAD | 2492.97% |
| 2020 Q4 | 79.07 Million CAD | 81.55% |
| 2019 Q4 | 2.02 Million CAD | -11.32% |
| 2019 FY | 2.02 Million CAD | -95.42% |
| 2019 Q3 | 2.27 Million CAD | -95.42% |
| 2019 Q2 | 49.8 Million CAD | -27.36% |
| 2019 Q1 | 68.55 Million CAD | 55.46% |
| 2018 Q4 | 44.1 Million CAD | -34.25% |
| 2018 FY | 44.1 Million CAD | 2725.23% |
| 2018 Q1 | -4.22 Million CAD | -370.82% |
| 2018 Q2 | 42.56 Million CAD | 1107.01% |
| 2018 Q3 | 67.07 Million CAD | 57.57% |
| 2017 Q2 | 2.31 Million CAD | 20.86% |
| 2017 Q1 | 1.91 Million CAD | 180.96% |
| 2017 FY | 1.56 Million CAD | 165.97% |
| 2017 Q4 | 1.56 Million CAD | 80.78% |
| 2017 Q3 | 863.44 Thousand CAD | -62.71% |
| 2016 Q4 | -2.36 Million CAD | -141.95% |
| 2016 Q3 | 5.64 Million CAD | -15.28% |
| 2016 Q2 | 6.65 Million CAD | 27.03% |
| 2016 Q1 | 5.24 Million CAD | 54.85% |
| 2016 FY | -2.36 Million CAD | -169.9% |
| 2015 FY | 3.38 Million CAD | 2570.98% |
| 2015 Q4 | 3.38 Million CAD | 66.17% |
| 2015 Q3 | 2.03 Million CAD | 18.19% |
| 2015 Q2 | 1.72 Million CAD | 47.13% |
| 2015 Q1 | 1.17 Million CAD | 120.46% |
| 2014 Q1 | -143.41 Thousand CAD | -2.14% |
| 2014 Q4 | -5.72 Million CAD | -4080.15% |
| 2014 Q3 | -136.99 Thousand CAD | 4.02% |
| 2014 Q2 | -142.73 Thousand CAD | 0.47% |
| 2014 FY | -136.99 Thousand CAD | 13.17% |
| 2013 FY | -157.78 Thousand CAD | 50.79% |
| 2013 Q1 | -207.58 Thousand CAD | 25.3% |
| 2013 Q2 | -164.08 Thousand CAD | 20.96% |
| 2013 Q3 | -157.78 Thousand CAD | 3.84% |
| 2013 Q4 | -140.4 Thousand CAD | 11.01% |
| 2012 Q4 | -277.91 Thousand CAD | 13.31% |
| 2012 Q3 | -320.59 Thousand CAD | 16.71% |
| 2012 Q2 | -384.93 Thousand CAD | -178.94% |
| 2012 Q1 | -138 Thousand CAD | 0.0% |
| 2012 FY | -320.59 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | -8.64 Million CAD | -289.79% |
| Avicanna Inc. | 1.32 Million CAD | 2641.775% |
| Avant Brands Inc. | 17.93 Million CAD | 288.003% |
| Cardiol Therapeutics Inc. | -34.77 Million CAD | 3.061% |
| Crescita Therapeutics Inc. | -8.13 Million CAD | -314.574% |
| Knight Therapeutics Inc. | 10.33 Million CAD | 426.321% |
| MediPharm Labs Corp. | -15.68 Million CAD | -114.899% |
| Canopy Growth Corporation | 512.87 Million CAD | 106.573% |
| Willow Biosciences Inc. | -989 Thousand CAD | -3308.392% |
| Auxly Cannabis Group Inc. | 142.88 Million CAD | 123.593% |